D. Parker Suttle

1.8k total citations
34 papers, 1.6k citations indexed

About

D. Parker Suttle is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, D. Parker Suttle has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 16 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in D. Parker Suttle's work include Biochemical and Molecular Research (17 papers), Cancer therapeutics and mechanisms (14 papers) and Peptidase Inhibition and Analysis (6 papers). D. Parker Suttle is often cited by papers focused on Biochemical and Molecular Research (17 papers), Cancer therapeutics and mechanisms (14 papers) and Peptidase Inhibition and Analysis (6 papers). D. Parker Suttle collaborates with scholars based in United States and Denmark. D. Parker Suttle's co-authors include William T. Beck, George R. Stark, Mary K. Danks, Patrick F. Coleman, Margaret C. Cirtain, Qingjian Wang, Gerard P. Zambetti, Carla Schmidt, John J. Kanalas and Joanne M. Ravel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

D. Parker Suttle

34 papers receiving 1.5k citations

Peers

D. Parker Suttle

ONCOL

GENET

Benjamin T. Vroman United States

Chen‐Chen Kan United States

Peter R. Twentyman United Kingdom

Yantao He United States

Renae M. Crosby United States

Frederick E. Durr United States

Baoguang Zhao United States

Ann‐Sofie Jemth Sweden

Suqin He United States

Shirley J. Petzold United States

Benjamin T. Vroman United States

D. Parker Suttle

1.1k ×0.8

732 ×1.1

ONCOL

103 ×0.8

168 ×1.3

GENET

38 ×0.3

Citations per year, relative to D. Parker Suttle D. Parker Suttle (= 1×) peers Benjamin T. Vroman

Countries citing papers authored by D. Parker Suttle

Since Specialization

Citations

This map shows the geographic impact of D. Parker Suttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Parker Suttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Parker Suttle more than expected).

Fields of papers citing papers by D. Parker Suttle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Parker Suttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Parker Suttle. The network helps show where D. Parker Suttle may publish in the future.

Co-authorship network of co-authors of D. Parker Suttle

This figure shows the co-authorship network connecting the top 25 collaborators of D. Parker Suttle. A scholar is included among the top collaborators of D. Parker Suttle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Parker Suttle. D. Parker Suttle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patil, Shivaputra A., Hemantkumar Deokar, Shan Sun, et al.. (2017). Synthesis, Biological Evaluation and Modeling Studies of New Pyrido[3,4-b] indole Derivatives as Broad-Spectrum Potent Anticancer Agents. PubMed. 6(1). 16 indexed citations

Suttle, D. Parker, et al.. (2003). Nuclear Factor-Y Binding to the Topoisomerase IIα Promoter Is Inhibited by Both the p53 Tumor Suppressor and Anticancer Drugs. Molecular Pharmacology. 63(2). 359–367. 17 indexed citations

Lothstein, Leonard, D. Parker Suttle, J. Brent Roaten, et al.. (2000). Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288). Biochemical Pharmacology. 60(11). 1621–1628. 13 indexed citations

Wang, Qingjian, et al.. (2000). p53 Modulation of DNA Topoisomerase IIα Gene Expression. Cell Biochemistry and Biophysics. 33(2). 209–216. 3 indexed citations

Chen, Guan, Dennis J. Templeton, D. Parker Suttle, & Dennis W. Stacey. (1999). Ras stimulates DNA topoisomerase IIα through MEK: A link between oncogenic signaling and a therapeutic target. Oncogene. 18(50). 7149–7160. 27 indexed citations

Wang, Qingjian, Gerard P. Zambetti, & D. Parker Suttle. (1997). Inhibition of DNA Topoisomerase IIα Gene Expression by the p53 Tumor Suppressor. Molecular and Cellular Biology. 17(1). 389–397. 141 indexed citations

Lin, Ti & D. Parker Suttle. (1995). UMP synthase activity expressed in deficient hamster cells by separate transferase and decarboxylase proteins or by linker-deleted bifunctional protein. Somatic Cell and Molecular Genetics. 21(3). 161–175. 1 indexed citations

Lin, Ti & D. Parker Suttle. (1993). Expression of catalytic domains of human UMP synthase in uridine auxotrophic bacteria. Somatic Cell and Molecular Genetics. 19(2). 193–202. 5 indexed citations

Beck, William T., Mary K. Danks, Judith S. Wolverton, et al.. (1993). Altered DNA topoisomerase II in multidrug resistance. Cytotechnology. 11(2). 115–119. 21 indexed citations

10.

Qumsiyeh, Mazin Β., Salil Goorha, & D. Parker Suttle. (1993). Gene amplification and chromosome rearrangements: a study of a single cell lineage selected for amplification and deamplification of the UMP synthase gene. Cytogenetic and Genome Research. 62(2-3). 162–168. 2 indexed citations

11.

Danks, Mary K., et al.. (1991). Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.. Proceedings of the National Academy of Sciences. 88(17). 7654–7658. 140 indexed citations

12.

Qumsiyeh, Mazin Β. & D. Parker Suttle. (1990). Localization of the Adenosine Deaminase, Transferrin, and UMP Synthetase Genes on Chinese Hamster Chromosomes 4 and 6 by in situ Hybridization. Journal of Heredity. 81(2). 111–116. 3 indexed citations

13.

Qumsiyeh, Mazin Β., Marcus B. Valentine, & D. Parker Suttle. (1989). Localization of the gene for uridine monophosphate synthase to human chromosome region 3q13 by in situ hybridization. Genomics. 5(1). 160–162. 11 indexed citations

14.

Qumsiyeh, Mazin Β. & D. Parker Suttle. (1989). Cytogenetic analysis of amplification and deamplification of UMP synthase genes in Chinese hamster cells. Somatic Cell and Molecular Genetics. 15(6). 503–512. 1 indexed citations

15.

Danks, Mary K., Carla Schmidt, Margaret C. Cirtain, D. Parker Suttle, & William T. Beck. (1988). Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry. 27(24). 8861–8869. 199 indexed citations

16.

Suttle, D. Parker, et al.. (1988). Molecular cloning and nucleotide sequence for the complete coding region of human UMP synthase.. Proceedings of the National Academy of Sciences. 85(6). 1754–1758. 57 indexed citations

17.

Kanalas, John J., John J. Hutton, & D. Parker Suttle. (1985). Characterization of pyrazofurin-resistant HeLa cells with amplification of UMP synthase gene. Somatic Cell and Molecular Genetics. 11(4). 359–369. 11 indexed citations

18.

Suttle, D. Parker, et al.. (1981). Pyrazofurin-resistant hepatoma cells deficient in adenosine kinase. European Journal of Cancer (1965). 17(1). 43–51. 6 indexed citations

19.

Suttle, D. Parker, et al.. (1979). The effects of initiation factors IF‐1 and IF‐3 on the dissociation of escherichia coli 70 S ribosomes. FEBS Letters. 97(1). 105–110. 19 indexed citations

20.

Suttle, D. Parker & George R. Stark. (1979). Coordinate overproduction of orotate phosphoribosyltransferase and orotidine-5'-phosphate decarboxylase in hamster cells resistant to pyrazofurin and 6-azauridine.. Journal of Biological Chemistry. 254(11). 4602–4607. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact